Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OneTAC: Conversion to Once-Daily Tacrolimus in Heart Transplant
NCT02545972Phase 4Unknown
- Sponsor
- Newark Beth Israel Medical Center
- Start
- Feb 2016
- Primary completion
- Nov 2018
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in heart transplant rejection, sponsored by Newark Beth Israel Medical Center. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
heart transplant rejection
Beyond the preview
Go deeper on NCT02545972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02545972.